# Efficacy and Safety of Qibei Jiedu Formula for Preventing and Managing Acute Radiation Dermatitis in Breast Cancer Patients

> **NCT07380230** · NA · NOT_YET_RECRUITING · sponsor: **LI FENG** · enrollment: 60 (estimated)

## Conditions studied

- Acute Radiation Dermatitis
- Traditional Chinese Medicine (TCM)
- Breast Cancer

## Interventions

- **DRUG:** Standard Basic Treatment Combined with Qibei Jiedu Formula
- **DRUG:** Standard Basic Treatment Combined with Qibei Jiedu Formula simulator

## Key facts

- **NCT ID:** NCT07380230
- **Lead sponsor:** LI FENG
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-01-27
- **Primary completion:** 2026-11-30
- **Final completion:** 2026-12-31
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-02-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07380230

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07380230, "Efficacy and Safety of Qibei Jiedu Formula for Preventing and Managing Acute Radiation Dermatitis in Breast Cancer Patients". Retrieved via AI Analytics 2026-09-13 from https://api.ai-analytics.org/clinical/NCT07380230. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*